A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma
Mayo Clinic
Mayo Clinic
Barbara Ann Karmanos Cancer Institute
City of Hope Medical Center
Northwestern University
Barbara Ann Karmanos Cancer Institute
M.D. Anderson Cancer Center
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Canadian Cancer Trials Group
Barbara Ann Karmanos Cancer Institute
Mayo Clinic
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Roswell Park Cancer Institute
Roswell Park Cancer Institute
Swiss Cancer Institute
Barbara Ann Karmanos Cancer Institute
M.D. Anderson Cancer Center
Wake Forest University Health Sciences
Wake Forest University Health Sciences
Ohio State University Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Wake Forest University Health Sciences
Massachusetts General Hospital
University of Washington
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Mayo Clinic
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)
Alliance for Clinical Trials in Oncology
Case Comprehensive Cancer Center
City of Hope Medical Center
City of Hope Medical Center
Indiana University
City of Hope Medical Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
INSYS Therapeutics Inc
National Cancer Institute (NCI)
Rutgers, The State University of New Jersey
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Asan Medical Center
National Cancer Institute (NCI)
City of Hope Medical Center